PICO Portalanswers from OpenAlex & ORCID
Thomas J. Lynch
ResearcherPublications, citations & collaboration network
Thomas J. Lynch is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Thomas J. Lynch have?
PICO Portalindexed works
Thomas J. Lynch has 399 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas J. Lynch have?
PICO Portalcitation count
Thomas J. Lynch has 56,140 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Thomas J. Lynch?
PICO Portalh-index
Thomas J. Lynch has an h-index of 84 in OpenAlex.
What is the i10-index of Thomas J. Lynch?
PICO Portali10-index
Thomas J. Lynch has an i10-index of 231 in OpenAlex.
What is the ORCID of Thomas J. Lynch?
PICO Portalorcid
The ORCID for Thomas J. Lynch is on the source record.
What is the OpenAlex record for Thomas J. Lynch?
PICO Portalopenalex
The OpenAlex for Thomas J. Lynch is on the source record.
What are the most-cited papers on Thomas J. Lynch?
PICO Portalmost cited works
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Jennifer S. Temel, Joseph A. Greer, Alona Muzikansky, Emily R. Gallagher, Sonal Admane, Vicki A. Jackson, Constance Dahlin, Craig D. Blinderman, Juliet Jacobsen, William F. Pirl, J. Andrew Billings, Thomas J. Lynch
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>
Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian W. Brannigan, Chey V. Collura, Elizabeth K. Inserra, Sven Diederichs, A. John Iafrate, Daphne W. Bell, Subba R. Digumarthy, Alona Muzikansky, Daniel Irimia, Jeffrey Settleman, Ronald G. Tompkins, Thomas J. Lynch, Mehmet Toner, Daniel A. Haber